Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.4.0.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2016
Dec. 31, 2015
Current assets    
Cash and cash equivalents $ 1,094,833 $ 1,201,112
Restricted cash 732,551 503,397
Accounts and interest receivable 23,979 5,749
Inventory 31,243 18,125
Other current assets 63,509 54,203
Total current assets 1,946,115 1,782,586
Non-current restricted cash 31,724 31,722
Property, plant and equipment, net 17,674,548 16,193,907
Debt issuance costs, net 409,894 378,677
Non-current derivative assets 29,361 30,887
Goodwill 76,819 76,819
Other non-current assets 262,486 314,455
Total assets 20,430,947 18,809,053
Current liabilities    
Accounts payable 35,398 22,820
Accrued liabilities 670,584 427,199
Current debt, net 1,785,318 1,673,379
Deferred revenue 26,669 26,669
Derivative liabilities 50,561 35,201
Other current liabilities 93 0
Total current liabilities 2,568,623 2,185,268
Long-term debt, net 16,348,099 14,920,427
Non-current deferred revenue 8,500 9,500
Non-current derivative liabilities 239,372 79,387
Other non-current liabilities $ 61,668 $ 53,068
Commitments and contingencies (see Note 14)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued $ 0 $ 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at March 31, 2016 and December 31, 2015; Issued and outstanding: 235.5 and 235.6 million shares at March 31, 2016 and December 31, 2015, respectively 707 708
Treasury stock: 11.7 million shares and 11.6 million shares at March 31, 2016 and December 31, 2015, respectively, at cost (354,903) (353,927)
Additional paid-in-capital 3,088,648 3,075,317
Accumulated deficit (3,944,786) (3,623,948)
Total stockholders’ deficit (1,210,334) (901,850)
Non-controlling interest 2,415,019 2,463,253
Total equity 1,204,685 1,561,403
Total liabilities and equity $ 20,430,947 $ 18,809,053